Ruggero Ridolfi Selected Research

Interleukin-8 (Interleukin 8)

8/2006

Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruggero Ridolfi Research Topics

Disease

28	Melanoma (Melanoma, Malignant) 01/2017 - 03/2002
21	Neoplasms (Cancer) 09/2014 - 03/2003
3	Renal Cell Carcinoma (Grawitz Tumor) 09/2014 - 01/2004
3	Neoplasm Metastasis (Metastasis) 05/2012 - 03/2003
3	Diarrhea 01/2012 - 09/2009
2	Disease Progression 05/2014 - 08/2006
2	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 07/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2011 - 02/2006
1	Spontaneous Abortion (Miscarriage) 03/2015
1	Metabolic Diseases (Metabolic Disease) 03/2015
1	Autistic Disorder (Autism) 03/2015
1	Brain Neoplasms (Brain Tumor) 09/2012
1	Kidney Neoplasms (Kidney Cancer) 05/2012
1	Thrombocytopenia 1 01/2012
1	Uveal melanoma 01/2012
1	Cardiotoxicity 04/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2010
1	Breast Neoplasms (Breast Cancer) 04/2010
1	Hypersensitivity (Allergy) 01/2010
1	Colitis 09/2009
1	Splenomegaly 09/2008
1	Lymphadenopathy 09/2008
1	Thrombocytopenia (Thrombopenia) 02/2006
1	Anemia 02/2006
1	Neutropenia 02/2006
1	Liver Diseases (Liver Disease) 12/2003
1	Fever (Fevers) 03/2002
1	Hyperthermia 03/2002
1	Arthralgia (Joint Pain) 03/2002
1	Myalgia 03/2002

Drug/Important Bio-Agent (IBA)

11	Interleukin-2 (IL2)IBA 09/2014 - 03/2002
8	IpilimumabIBA 05/2014 - 09/2009
4	VaccinesIBA 01/2017 - 01/2010
4	CytokinesIBA 09/2014 - 08/2006
4	Neoplasm Antigens (Tumor Antigens)IBA 09/2014 - 12/2003
4	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 05/2013 - 08/2006
3	AntigensIBA 09/2014 - 06/2010
2	AntibodiesIBA 01/2017 - 02/2008
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2014 - 03/2002
2	Gemcitabine FDA Link 01/2014 - 02/2006
2	Temozolomide (Temodar)FDA LinkGeneric 05/2013 - 08/2004
2	fotemustine (Muphoran)IBA 09/2012 - 04/2009
2	SteroidsIBA 01/2012 - 09/2009
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2012 - 09/2009
2	Cisplatin (Platino)FDA LinkGeneric 04/2009 - 03/2002
2	Interferon-alpha (Interferon Alfa)IBA 04/2009 - 08/2004
2	InterferonsIBA 02/2006 - 03/2002
2	Dacarbazine (DIC)FDA LinkGeneric 08/2004 - 03/2002
1	Environmental Pollutants (Pollutants, Environmental)IBA 03/2015
1	Biomarkers (Surrogate Marker)IBA 09/2014
1	MicroRNAs (MicroRNA)IBA 06/2014
1	dabrafenibIBA 05/2014
1	VemurafenibIBA 05/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014
1	Fluorouracil (Carac)FDA LinkGeneric 01/2014
1	Alanine (L-Alanine)FDA Link 01/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2012
1	Dihydrotachysterol (AT 10)IBA 01/2012
1	Monoclonal AntibodiesIBA 01/2012
1	Histocompatibility Antigens Class IIIBA 06/2010
1	Peptides (Polypeptides)IBA 06/2010
1	HLA-DR Antigens (HLA-DR)IBA 06/2010
1	Immunoglobulin G (IgG)IBA 06/2010
1	Epirubicin (Ellence)FDA LinkGeneric 04/2010
1	liposomal doxorubicin (Doxil)FDA Link 04/2010
1	AnthracyclinesIBA 04/2010
1	Capecitabine (Xeloda)FDA Link 04/2010
1	Messenger RNA (mRNA)IBA 01/2010
1	Cancer VaccinesIBA 01/2010
1	Proteins (Proteins, Gene)FDA Link 01/2010
1	Interleukin-8 (Interleukin 8)IBA 08/2006
1	Interleukin-12 (IL 12)IBA 08/2006
1	Interleukin-10 (Interleukin 10)IBA 08/2006
1	Interleukin-6 (Interleukin 6)IBA 08/2006
1	Interferon alpha-2 (Roferon-A)FDA Link 02/2006
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2006
1	Carboplatin (JM8)FDA LinkGeneric 02/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2006
1	Alkylating AgentsIBA 08/2004
1	Environmental BiomarkersIBA 07/2004
1	Fibrinogen (Factor I)FDA Link 12/2003
1	InterleukinsIBA 03/2003
1	Fas Ligand Protein (Fas Ligand)IBA 03/2003
1	Carmustine (FIVB)FDA Link 03/2002

Therapy/Procedure

10	Immunotherapy 06/2014 - 03/2002
9	Therapeutics 01/2013 - 03/2002
8	Drug Therapy (Chemotherapy) 01/2014 - 03/2002
6	Biological Therapy 12/2013 - 02/2008
2	Radiotherapy 09/2014 - 07/2014
1	Retreatment 05/2014
1	EAP protocol 10/2013
1	Withholding Treatment 06/2012
1	Erythrocyte Transfusion 02/2006
1	Nephrectomy 01/2004
1	Metastasectomy 03/2003
1	Intralesional Injections 03/2002